This gene set was heavily enriched with myeloid leukemia drivers (e.g., FLT3, RUNX1, CD33) and other tumor-promoting genes, providing a direct mechanistic link between eccDNA presence and the transcriptional dysregulation that fuels AML. This evidence concerns the gene CD33 and neoplasm.